These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6113428)

  • 1. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.
    Darragh A; Lambe R; Scully M; Brick I; O'Boyle C; Downe WW
    Lancet; 1981 Jul; 2(8236):8-10. PubMed ID: 6113428
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of benzodiazepine-induced sedation by intravenous Ro 15-1788.
    Darragh A; Lambe R; Brick I; Downie WW
    Lancet; 1981 Nov; 2(8254):1042. PubMed ID: 6118493
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of slow-wave sleep by benzodiazepine antagonist Ro 15-1788.
    Ziegler G; Ludwig L; Fritz G
    Lancet; 1985 Aug; 2(8453):510. PubMed ID: 2863538
    [No Abstract]   [Full Text] [Related]  

  • 4. Antagonism of the central effects of 3-methylclonazepam.
    Darragh A; Lambe R; Brick I; O'Boyle C
    Br J Clin Pharmacol; 1982 Dec; 14(6):871-2. PubMed ID: 6817773
    [No Abstract]   [Full Text] [Related]  

  • 5. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
    O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
    Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?
    Klotz U; Ziegler G; Rosenkranz B; Mikus G
    Br J Clin Pharmacol; 1986 Nov; 22(5):513-20. PubMed ID: 3098270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal.
    Emrich HM; Sonderegger P; Mai N
    Neurosci Lett; 1984 Jun; 47(3):369-73. PubMed ID: 6433243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
    Schöpf J; Laurian S; Le PK; Gaillard JM
    Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.
    Darragh A; Lambe R; Kenny M; Brick I; Taaffe W; O'Boyle C
    Br J Clin Pharmacol; 1982 Nov; 14(5):677-82. PubMed ID: 6814472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical investigation of Ro 15-1788, a benzodiazepine antagonist, in reversing the central effects of flunitrazepam.
    Jensen S; Kirkegaard L; Anderson BN
    Eur J Anaesthesiol; 1987 Mar; 4(2):113-8. PubMed ID: 3109893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788.
    Darragh A; Lambe R; O'Boyle C; Kenny M; Brick I
    Psychopharmacology (Berl); 1983; 80(2):192-5. PubMed ID: 6410450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.
    Klotz U; Ziegler G; Reimann IW
    Eur J Clin Pharmacol; 1984; 27(1):115-7. PubMed ID: 6436030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the benzodiazepine antagonist Ro 15-1788 on flunitrazepam-induced sleep changes.
    Gaillard JM; Blois R
    Br J Clin Pharmacol; 1983 May; 15(5):529-36. PubMed ID: 6134542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    Klotz U; Duka T; Dorow R; Doenicke A
    Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The action of the benzodiazepine antagonist Ro 15-1788].
    Doenicke A; Suttmann H; Kapp W; Kugler J; Ebentheuer H
    Anaesthesist; 1984 Aug; 33(8):343-7. PubMed ID: 6148904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of benzodiazepines on interneuronal transmission in afferent systems and their antagonism with Ro 15-1788].
    Kharkevich DA; Sinitsyn LN; Churiukanov VV; Fisenko VP; Chichenikov ON
    Farmakol Toksikol; 1983; 46(5):14-9. PubMed ID: 6138277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of schistosomicide derivatives, appreciation with electronic microscopy experimental model (author's transl)].
    Forget E; Félix H; Notteghem MJ; Léger N
    Bull Soc Pathol Exot Filiales; 1982; 75(2):192-200. PubMed ID: 6809349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.